'We Should Have Acted Sooner' On DTC Gene Tests, Shuren Tells Lawmakers

CDRH has been busy for the past two months in an effort to bring direct-to-consumer genetic test services into its regulatory fold, but Center Director Jeff Shuren acknowledged to a House subcommittee last week that the agency was slow to tackle the matter

More from Archive

More from Medtech Insight